Comparison of Disease-Modifying Therapies for the Management of Multiple Sclerosis: Analysis of Healthcare Resource Utilization and Relapse Rates from US Insurance Claims Data
Crossref DOI link: https://doi.org/10.1007/s41669-017-0035-2
Published Online: 2017-08-09
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nicholas, Jacqueline
Boster, Aaron
Wu, Ning
Yeh, Wei-Shi
Fay, Monica
Kendter, Jon
Huang, Ming-Yi
Lee, Andrew
Funding for this research was provided by:
Biogen
License valid from 2017-08-09